Hangzhou Biotest Biotech Co., LTD. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and equipment in China and Internationally. It offers medical test products for fertility health, oncology, cardiology, inflammation, biochemistry, and various infectious diseases, as well as COVID-19 rapid tests, such as antibody and antigen testing kits; and urine and saliva drug, hair drug, and vitamin D rapid testing kits. The company also provides immunochromatography readers and fluorescence immunoassay quantitative analyzers. Hangzhou Biotest Biotech Co., LTD. was founded in 2008 and is based in Hangzhou, China.

6887

SHH:688767

Hangzhou Biotest Biotech Co.,Ltd.

Last Close

26.90

30/08 07:00

Market Cap

2.74B

Beta: -

Volume Today

1.71M

Avg: 477.69K

PE Ratio

−122.72

PFCF: −32.23

Dividend Yield

9.43%

Payout:−42.81%

locale

market

industry

website

ipo date

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics